Canadian Association of Pharmacy
in Oncology (CAPhO) Conference 2017
The Evolving Landscape of Patient Management
in Hormone Positive Breast Cancer
APRIL
21st
Chair: Dr Karen Gelmon, M.D.
Medical Oncologist, Dept. of Medical Oncology,
BC Cancer Agency (BCCA)
Head Investigational Drug Program, Experimental Therapeutics
Panelist: Kimberly Kuik, BScPharm
Pharmacy Professional Practice Leader,
BC Cancer Agency
Panelist: Terry Playfair, Patient
Pfizer Oncology Symposium Session
Alhambra room • 14:00 - 15:30
Learning Objectives:
• Describe therapeutic approaches for the treatment
of hormone-positive breast cancer: past history to
the present day of endocrine therapy
• Understand the implications of the evidence on
patient management